(Q37109488)

18 August 2017

title

Changes in causes of death over time after treatment for invasive aspergillosis (English)

1 reference

18 August 2017

0 references

4

Raoul Herbrecht

1 reference

18 August 2017

John R Wingard

1

1 reference

18 August 2017

Patricia Ribaud

series ordinal

2

1 reference

18 August 2017

Haran T Schlamm

series ordinal

3

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 May 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

112

1 reference

18 August 2017

issue

10

1 reference

18 August 2017

page(s)

2309-2312

1 reference

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23441

A double-blind, randomized, controlled trial of amphotericin B colloidal dispersion versus amphotericin B for treatment of invasive aspergillosis in immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23441

Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23441

Combination antifungal therapy for invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23441

Trial design for mold-active agents: time to break the mold--aspergillosis in neutropenic adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23441

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CNCR.23441

1 reference

18 August 2017

1 reference